loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Tegoprazan

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Tegoprazan

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Malaysia Approves RaQualia's Tegoprazan For GERD Treatment
    Malaysia Approves RaQualia's Tegoprazan For GERD Treatment

    27 Sep 2024

    // BIOSPECTRUM ASIA

    https://www.biospectrumasia.com/news/25/24961/malaysia-gives-nod-to-raqualias-tegoprazan-for-gastroesophageal-reflux-disease-treatment.html

    BIOSPECTRUM ASIA
    27 Sep 2024
    Share Share
    Sebela Acquires Licensing Rights to Develop and Commercialize Tegoprazan
    Sebela Acquires Licensing Rights to Develop and Commercialize Tegoprazan

    20 Oct 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/sebela-pharmaceuticals-acquires-exclusive-licensing-rights-to-develop-and-commercialize-tegoprazan-in-the-us-and-canada-301654039.html

    PRNEWSWIRE
    20 Oct 2022
    Share Share
    Dr. Reddy’s Laboratories to commercialise novel molecule Tegoprazan in India
    Dr. Reddy’s Laboratories to commercialise novel molecule Tegoprazan in India

    11 May 2022

    // FINANCIAL EXPRESS

    https://www.financialexpress.com/healthcare/pharma-healthcare/dr-reddys-laboratories-to-commercialise-novel-molecule-tegoprazan-in-india/2520304/

    FINANCIAL EXPRESS
    11 May 2022
    Share Share
    Combo drugs: latest trend in local pharmaceuticals
    Combo drugs: latest trend in local pharmaceuticals

    19 Aug 2019

    // Lee Hye-seon KOREAMED

    http://www.koreabiomed.com/news/articleView.html?idxno=6300

    Lee Hye-seon KOREAMED
    19 Aug 2019
    Share Share